This provider of implantable medical devices to hospitals and ambulatory surgery centers has seen two negative estimate revisions in the last 30 days. The Zacks Consensus Estimate has also moved lower over the same period. This implies trouble down the road. So make sure to keep an eye on this stock going forward to see if yesterday’s rally can last.
Cyberonics currently has a Zacks Rank #4 (Sell) while its Earnings ESP is negative.
Investors interested in the biomedical industry may consider stocks like AngioDynamics Inc. (ANGO), Edwards Lifesciences Corp. (EW) and EnteroMedics Inc. (ETRM). While AngioDynamics sports a Zacks Rank #1 (Strong Buy), Edwards Lifesciences and EnteroMedics hold a Zacks Rank #2 (Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
To read this article on Zacks.com click here.
Get all Zacks Research Reports and be alerted to fast-breaking buy and sell opportunities every trading day.
Be the first to comment